ADALIMUMAB LONG-TERM EFFECTIVENESS IN ADALIMUMAB-NAIVE PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRY

被引:0
|
作者
Loftus, Edward V.
D'Haens, Geert R.
Reinisch, Walter
Satsangi, Jack
Panaccione, Remo
Berg, Sofie
Alperovich, Gabriela
Bereswill, Mareike
Skup, Martha
Petersson, Joel H.
Robinson, Anne M.
机构
关键词
D O I
10.1016/S0016-5085(17)32582-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1661
引用
收藏
页码:S743 / S743
页数:1
相关论文
共 50 条
  • [41] Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry
    Klein, A.
    Becker, I.
    Minden, K.
    Foeldvari, I.
    Haas, J. P.
    Horneff, G.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2019, 48 (02) : 95 - 104
  • [42] Long-term retention of adalimumab treatment and associated prognostic factors for 1189 patients with Crohn's disease
    Tanaka, Hiroki
    Kamata, Noriko
    Yamada, Akihiro
    Endo, Katsuya
    Fujii, Toshimitsu
    Yoshino, Takuya
    Sugaya, Takeshi
    Yokoyama, Yoko
    Bamba, Shigeki
    Umeno, Junji
    Yanai, Yuka
    Ishii, Manabu
    Kawaguchi, Takaaki
    Shinzaki, Shinichiro
    Toya, Yosuke
    Kobayashi, Taku
    Nojima, Masanori
    Hibi, Toshifumi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (05) : 1031 - 1038
  • [43] Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis
    Colombel, J. -F.
    Sandborn, W. J.
    Reinisch, W.
    Peyrin-Biroulet, L.
    Panaccione, R.
    Rutgeerts, P.
    Hanauer, S. B.
    Ghosh, S.
    Van Assche, G.
    Robinson, A. M.
    Lau, W.
    Maa, J. -F.
    Huang, B.
    Pappalardo, B.
    Read, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 219 - 228
  • [44] Long-Term Safety of Adalimumab in Clinical Trials in Adult Patients With Crohn's Disease or Ulcerative Colitis
    Sandborn, William J.
    Colombel, Jean-Frederic
    Panaccione, Remo
    Ghosh, Subrata
    Rutgeerts, Paul
    Hanauer, Stephen
    Van Assche, Gert
    Reinisch, Walter
    Peyrin-Biroulet, Laurent
    Robinson, Anne
    Lau, Winnie
    Huang, Bidan
    Pappalardo, Brandee
    Read, Holly
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S789 - S790
  • [45] Impact of long-term Adalimumab treatment on fistula healing in patients with moderate to severe Crohn's Disease
    Colombel, J.
    Kamm, M.
    Schwartz, D.
    Panaccione, R.
    Li, J.
    Lomax, K.
    Pollack, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S32 - S32
  • [46] New Demyelinating CNS Lesions in Crohn's Disease Patient on Long-term Adalimumab
    Bartosz, Caren
    Tsynman, Donald
    Ullah, Asad
    Shah, Ashok
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S418 - S419
  • [47] Successfully multiple pregnancies in Crohn's disease under long-term treatment with adalimumab
    Tursi, Antonio
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2013, 76 (02) : 264 - 265
  • [48] LONG TERM ADALIMUMAB EFFICACY IN STEROID-DEPENDENT CROHN'S DISEASE PATIENTS
    Orlando, A.
    Renna, S.
    Mocciaro, F.
    Cappello, M.
    Bravata, I.
    Di Mitri, R.
    Craxi, A.
    Cottone, M.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S76 - S76
  • [49] PROGNOSTIC FACTORS FOR LONG-TERM ADALIMUMAB TREATMENT IN CROHN'S DISEASE : A MULTICENTER EXPERIENCE
    Pariente, Benjamin
    Duveau, Nicolas
    Perignon, Claire-Anne
    Lepeut, Gabriel
    Lahaye, Anouck
    le Baut, Guillaume
    Rouillon, Clea
    Yzet, Clara
    Loreau, Julien
    Wils, Pauline
    Nachury, Maria
    Fumery, Mathurin
    Viennot, Stephanie
    GASTROENTEROLOGY, 2019, 156 (06) : S879 - S879
  • [50] Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis
    Hart, Ailsa
    D'Haens, Geert
    Bereswill, Mareike
    Finney-Hayward, Tricia
    Kalabic, Jasmina
    Levy, Gweneth
    Liang, Huifang
    Seow, Cynthia H.
    Loftus, Edward V., Jr.
    Panaccione, Remo
    Reinisch, Walter
    Satsangi, Jack
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2022, 10 (05) : 485 - 495